Company
Oxford BioDynamics PLC
LON:OBD
Oxford BioDynamics Plc (AIM: OBD) is a biotechnology company focused on the discovery and development of epigenetic biomarkers for use in clinical diagnostics and precision medicine. Its proprietary EpiSwitch® platform enables the detection of 3D genomic markers with wide applications in immuno-oncology, neurodegeneration, and pharmacogenomics
38 stories · page 1 of 2
Archive
Time Out's plans for a food court at Waterloo station bites the dust
A look at some of the major movers in London on Tuesday
Archive
FTSE 100 closes below its opening benchmark as trade war concerns cloud market sentiment
The UK blue-chip index ended 7.78 points lower at 7,265.98, just off the day's worst level of 7,263.80 after a topsy-turvey session which saw it hit a session high of 7,314.85 early on
Archive
Enjoy the UK bank holiday, because there will be little else to get excited about in the coming week
The shortened trading Week Ahead will only bring updates from the likes of second-liners FirstGroup, Pennon, Wizz Air, and Daily Mail & General Trust
Oxford Biodynamics reports narrower annual losses, commercial projects underway
The biotech group said annual revenue was flat but that spending on staff and R&D had grown